Rosiglitazone, a PPARγ agonist, ameliorates palmitate‐induced insulin resistance and apoptosis in skeletal muscle cells
Year: 2014
Type: article
Source: Cell Biochemistry and Function
DOI: 10.1002/cbf.3072
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1603928832
